Joshua Rosenblat

25PUBLICATIONS
85CO-AUTHORS
Psychological methodology, design and analysisPharmacogenomicsToxicology (incl. clinical toxicology)Clinical pharmacology and therapeuticsClinical psychology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (25)

|Jun 24, 2026
Evaluating the abuse liability of ketamine in the treatment of mood disorders: A systematic review.

|May 28, 2026
The Serotonin 2B (5-HT2B) Receptor: A Narrative Review of Preclinical and Clinical Evidence on the Safety Considerations and Therapeutic Potential for the Treatment of Depression.

|May 06, 2026
Esketamine for major depressive disorder: pharmacokinetics and toxicological considerations.

|Feb 28, 2026
Progress, potential and pitfalls of ketamine as a treatment for depression.

Diana K Orsini, Sara Di Luch, Gabrielle F M Lovell

|Nov 18, 2025
The Canadian Network for Mood and Anxiety Treatments Task Force Recommendations for the Use of Probiotics, Prebiotics, Synbiotics, and Fecal Microbiota Transplants in Adults With Major Depressive Disorder: Recommandations du Groupe de travail du Réseau canadien pour le traitement des troubles de l'humeur et de l'anxiété (Canadian Network for Mood and Anxiety Treatments, CANMAT) concernant l'utilisation des probiotiques, des prébiotiques, des symbiotiques et de la transplantation de microbiote fécal chez les adultes atteints de trouble dépressif majeur.

Anees Bahji, Elisa Brietzke, Noah C A Cooke

|Oct 22, 2025
Biological markers of treatment response to serotonergic psychedelic therapies: a systematic review.

Stanley Wong, Brett D M Jones, Mathura T Thiyagarajah

Pageof 5

Frequent Collaborators

8 joint publications

Roger S McIntyre

3 joint publications

Roger Nelson Rodrigues

3 joint publications

Gabrielle Lovell

3 joint publications

Serge Beaulieu